Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.0B
218M shares
52-week range
$9.18 – $31.18
17% from low
Sector
INSURANCE AGENTS, BROKERS & SERVICE
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $103.2M | $213.1M | $329.7M | $597.7M | $879.5M |
| Cost of revenue | $39.7M | $134.5M | $130.2M | $248.7M | $284.3M |
| Gross profit | $63.5M | $78.6M | $199.5M | $349.0M | $595.2M |
| Gross margin | 61.5% | 36.9% | 60.5% | 58.4% | 67.7% |
| R&D | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$20.0M | −$84.3M | −$43.9M | $32.0M | −$1.32B |
| EBITDA | −$15.5M | −$74.3M | −$14.3M | $91.0M | −$1.22B |
| Net income | −$21.5M | −$91.7M | −$48.8M | $27.2M | −$1.35B |
| Net margin | -20.8% | -43.0% | -14.8% | 4.6% | -154.0% |
| EPS (diluted) | -0.10 | -0.55 | -0.23 | 0.13 | -7.49 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.1B | $0.74 | $0.71–$0.76 | 5 |
| 2027 | $1.2B | $0.93 | $0.88–$0.98 | 5 |
| 2028 | $1.4B | $1.23 | $1.12–$1.33 | 1 |
| 2029 | $1.7B | $1.69 | $1.53–$1.82 | 1 |
Forward consensus · source: Financial Modeling Prep
Accelerant Holdings operates as a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners. The company operates in three segments: Exchange Services, MGA Operations, and Underwriting. The majority of its revenue is generated from the Underwriting segment, which contains all revenue and expenses associated with the underwriting of insurance policies and assumption of reinsurance policies issued or accepted by Accelerant's consolidated insurance and reinsurance companies. Geographically, it operates in North America, the UK, and the EU, out of which it derives maximum revenue from North America.
www.accelerant.aiNo one on the platform currently holds ARX.
No tracked institution reports a position in ARX as of their last filing.
No one on the platform has traded ARX yet.
| $1.8B |
| — |
| HCIHCI Group, Inc. | $178.77 | -0.94% | $2.3B | — |
| HGHamilton Insurance Group, Ltd. | $33.73 | +0.54% | $3.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$ARX 343 shares added to the collection. $MRVL $SNOW $MARA $INTC Also added to
View on StockTwits ↗$ARX The company has been growing substantially faster than most insurance peers. Exchange Written Premium grew roughly 35% year over year!!
View on StockTwits ↗@SouthernItUp smart man... you seen $ARX ? Trading meh but looks decent
View on StockTwits ↗$CNXU : Building Tissue Instead of Replacing It Conexeu Sciences is a regenerative medicine company developing its proprietary CXU platform to help the body naturally repair and regenerate tissue. Recent milestones and catalysts: ✅ Commenced trading on Nasdaq under ticker $ CNXU, bringing a newly public regenerative medicine story to the market ✅ Advancing its proprietary CXU platform with a one platform, multiple indications strategy spanning tissue repair, wound care, aesthetics, reconstruction and regenerative applications ✅ Building on more than a decade of research originating from the University of British Columbia and wound healing research programs CNXU isn’t chasing a single indication. It’s building across markets projected in the tens of billions, including a $17.8B advanced wound care opportunity and a regenerative medicine market expected to exceed $22B. Communicated Disclaimer: https://stockresearchtoday.com/cnxu/ Sector Peers: $MDXG $IART $ARX
View on StockTwits ↗$ARX — Warrant Holdings. Specialty insurer operating through Lloyd's of London — property catastrophe, marine, aviation, niche reinsurance. Hard insurance market = pricing power. Iran war + geopolitical risk = elevated demand for exactly what ARX writes. Broke out of a massive falling wedge after a 70% drawdown. Targets already mapped. 🐂 $16.56 reclaim = Bull Target 1 at $22.15 in play. Bull Target 2 at $30.40 on full wedge measured move. Hard market + geopolitical premium = fundamental catalyst. 🐻 Green trendline fails = Bear Target 1 at $8.09. Below $12.62 HVN = thesis broken. ⚠️ Wedge breakout confirmed. Higher lows building. RSI at 60+ off 20. Iran war is literally good for specialty marine/aviation insurance pricing. Asymmetric setup.#ARX #WarrantHoldings #Insurance #Reinsurance #Lloyds #TechnicalAnalysis #hovdid
View on StockTwits ↗$ARX the market is giving this stock every chance to continue.
View on StockTwits ↗$ARX Accelerant (ARX) Q1 2026 Earnings Transcript https://marketwirenews.com/stock/arx/news/accelerant-arx-q1-2026-earnings-transcript-4886181407641025.html?utm_source=stocktwits
View on StockTwits ↗https://marketbeat.com/a/8654566/ $ARX Accelerant Q1 Earnings Call Highlights
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.